0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Intellectual Landscape of Nanovaccines: A Bibliometric Perspective on Scientific Progress and Future Directions

      review-article
      1 , , 2 , 3 , 4 , 5
      ,
      Cureus
      Cureus
      nano-vaccine, citespace, biblioshiny, biblimetric analysis, nanovaccine, nano vaccine

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This bibliometric study provides a comprehensive analysis of the burgeoning field of nanovaccine research, leveraging data sourced from Scopus and employing the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) flowchart for the meticulous screening, inclusion, and exclusion of relevant studies. Utilizing sophisticated bibliometric tools, such as Biblioshiny and CiteSpace, we dissected the expansive literature to unearth critical insights into the annual scientific output, identifying key contributors and pivotal publications that have shaped the domain. The analysis delineates the most influential authors, sources, and globally cited documents, offering a macroscopic view of the field’s intellectual structure and growth trajectory. Trend topics and thematic mapping underscored the evolution of research foci, from fundamental immunological mechanisms to cutting-edge nanomaterial applications. Factorial analysis and keyword co-occurrence networks revealed the intricate associations and thematic concentrations within the literature. The study’s robust methodology also pinpointed the keywords exhibiting the strongest citation bursts, signifying emergent areas of intense academic interest. Networks of cited authors illuminated collaborative patterns among scholars, while timeline network visualizations of country collaborations depicted the global interplay in nanovaccine development. Crucially, this study identified notable research gaps and practical implications, suggesting directions for future investigation and highlighting the translational potential of nanovaccines in public health and personalized medicine. This bibliometric investigation not only maps the current landscape but also charts a course for the trajectory of nanovaccine research, emphasizing its role as a cornerstone of innovative immunotherapeutic strategies.

          Related collections

          Most cited references48

          • Record: found
          • Abstract: not found
          • Article: not found

          The journal coverage of Web of Science and Scopus: a comparative analysis

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Google Scholar, Scopus and the Web of Science: a longitudinal and cross-disciplinary comparison

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A STING-Activating Nanovaccine for Cancer Immunotherapy

              Generation of tumor-specific T cells is critically important for cancer immunotherapy 1,2 . A major challenge in achieving a robust T cell response is the spatio-temporal orchestration of antigen cross-presentation in antigen presenting cells (APCs) with innate stimulation. Here we report a minimalist nanovaccine by a simple physical mixture of an antigen with a synthetic polymeric nanoparticle, PC7A NP, which generated a strong cytotoxic T cell response with low systemic cytokine expression. Mechanistically, PC7A NP achieved efficient cytosolic delivery of tumor antigens to APCs in draining lymph nodes leading to increased surface presentation while simultaneously activating type I interferon-stimulated genes. This effect was dependent on STING but not Toll-like receptor or MAVS pathway. Nanovaccine produced potent tumor growth inhibition in melanoma, colon cancer, and human papilloma virus-E6/E7 tumor models. Combination of PC7A nanovaccine with an anti-PD-1 antibody showed great synergy with 100% survival over 60 days in a TC-1 tumor model. Rechallenging of these tumor-free animals with TC-1 cells led to complete inhibition of tumor growth, suggesting generation of long-term antitumor memory. The STING-activating nanovaccine offers a simple, safe and robust strategy in boosting anti-tumor immunity for cancer immunotherapy.
                Bookmark

                Author and article information

                Journal
                Cureus
                Cureus
                2168-8184
                Cureus
                Cureus (Palo Alto (CA) )
                2168-8184
                12 May 2024
                May 2024
                : 16
                : 5
                : e60131
                Affiliations
                [1 ] Library, Marian College Kuttikkanam (Autonomous), Kuttikkanam, IND
                [2 ] Physics, St. Peter's College, Kolenchery, Kolenchery, IND
                [3 ] Physics, Nair Service Society (NSS) College, Nilamel, Kollam, IND
                [4 ] Library, St. Peter's College, Kolenchery, Kolenchery, IND
                [5 ] Library, St. Thomas College, Palai (Autonomous), Palai, IND
                Author notes
                Article
                10.7759/cureus.60131
                11167401
                38868255
                a4e0bb98-0177-49c1-a45d-a999f8ff9f6d
                Copyright © 2024, Jose et al.

                This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 12 May 2024
                Categories
                Medical Physics

                nano-vaccine,citespace,biblioshiny,biblimetric analysis,nanovaccine,nano vaccine

                Comments

                Comment on this article